ReviR Therapeutics is based in South San Francisco, California. It has raised $55M in total funding. Latest round: Seed.
ReviR Therapeutics funding overview
ReviR Therapeutics is based in South San Francisco, California. ReviR Therapeutics has raised $55M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Seed announced in March 2025. The round record for ReviR Therapeutics runs through 2025; nothing later has been disclosed. Investors on record include Lapam Capital, CDH Investments, 5Y Capital, Yael Capital, Xtalpi, CMT Research Foundation and 3 others. 9 distinct backers are named across the disclosed rounds.
ReviR Therapeutics at a glance
Total raised
$55M
Latest round
Seed
Latest round date
March 2025
Headquarters
South San Francisco, California
Notable investors
Lapam Capital, CDH Investments, 5Y Capital, Yael Capital, Xtalpi, CMT Research Foundation, Shunwei Capital, Sky9 Capital
Frequently asked about ReviR Therapeutics funding
How much has ReviR Therapeutics raised?
ReviR Therapeutics has raised $55M in total disclosed funding across the rounds on record.
Who has invested in ReviR Therapeutics?
Lapam Capital, CDH Investments, 5Y Capital, Yael Capital, Xtalpi, CMT Research Foundation are named among the investors backing ReviR Therapeutics.
What was the latest ReviR Therapeutics funding round?
The most recent disclosed round is a Seed, announced in March 2025.
Where is ReviR Therapeutics based?
ReviR Therapeutics is based in South San Francisco, California.
When did ReviR Therapeutics last raise?
The last disclosed ReviR Therapeutics round closed in March 2025 at Seed.
We update the ReviR Therapeutics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in South San Francisco and their backers are listed below.
